Pfizer
PFE
2,810 hedge funds and large institutions have $90.8B invested in Pfizer in 2025 Q2 according to their latest regulatory filings, with 142 funds opening new positions, 1,176 increasing their positions, 1,233 reducing their positions, and 230 closing their positions.
0.62% less ownership
Funds ownership: 66.26% → 65.64% (-0.62%)
5% less repeat investments, than reductions
Existing positions increased: 1,176 | Existing positions reduced: 1,233
4% less funds holding
Funds holding: 2,931 → 2,810 (-121)
7% less capital invested
Capital invested by funds: $97.4B → $90.8B (-$6.64B)
21% less call options, than puts
Call options by funds: $2.61B | Put options by funds: $3.32B
34% less funds holding in top 10
Funds holding in top 10: 44 → 29 (-15)
38% less first-time investments, than exits
New positions opened: 142 | Existing positions closed: 230
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$483M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$243M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$238M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$183M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$177M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$618M |
| 2 |
Amundi
Paris,
France
|
-$341M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$318M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$312M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$250M |
PFE Hedge Fund Activity: Q2 2025 in Review
2,810 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2025, worth a combined $90.8B — down 6.8% from $97.4B a quarter earlier.
Sellers outnumbered buyers: 230 funds closed out of PFE and 142 opened new positions — a net loss of 88 holders — while 1,233 trimmed existing stakes and 1,176 added.
The largest buyer was BlackRock, adding an estimated $483M. The largest seller was Wellington Management Group, cutting an estimated $618M.
- 2,810 institutional investors held Pfizer (PFE) as of Q2 2025, down from 2,931 in Q1 2025.
- Funds reported $90.8B of Pfizer stock for Q2 2025, down 6.8% quarter-over-quarter.
- 142 funds opened new Pfizer positions in Q2 2025 and 230 closed out, a net change of -88 holders.
- The largest Pfizer buyer in Q2 2025 was BlackRock, an estimated $483M added.
- The largest Pfizer seller in Q2 2025 was Wellington Management Group, an estimated $618M sold.
Based on aggregated 13F filings for Q2 2025.